Scancell Holdings plc (AIM:SCLP)
85.00
-1.40 (-1.62%)
Nov 4, 2026, 4:35 PM GMT
Scancell Holdings Employees
Scancell Holdings had 55 employees as of April 30, 2026. The number of employees decreased by 5 or 8.33% compared to the previous year. That makes Scancell Holdings the 34,478th largest employer in the world and 693rd in the United Kingdom.
Employees
55
Change (1Y)
-5
Growth (1Y)
-8.33%
Revenue / Employee
n/a
Profits / Employee
-325.47K GBP
Market Cap
103.04M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Apr 30, 2026 | 55 | -5 | -8.33% |
| Apr 30, 2025 | 60 | -1 | -1.64% |
| Apr 30, 2024 | 61 | 10 | 19.61% |
| Apr 30, 2023 | 51 | 11 | 27.50% |
| Apr 30, 2022 | 40 | 15 | 60.00% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| 4basebio | 140 |
| PureTech Health | 90 |
| Avacta Group | 81 |
| IXICO | 79 |
| Faron Pharmaceuticals Oy | 36 |
| Arecor Therapeutics | 33 |
| Hemogenyx Pharmaceuticals | 16 |
| Poolbeg Pharma | 15 |
Scancell Holdings News
- 26 days ago - Scancell Holdings Annual report: H2 2026 - Filings
- 7 weeks ago - Scancell Holdings Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 2 months ago - Scancell Holdings Slides: Corporate presentation - Filings
- 6 months ago - Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study - GlobeNewsWire
- 9 months ago - Scancell Holdings Earnings Call Transcript: H1 2026 - Transcripts
- 9 months ago - Scancell Holdings Quarterly report: H1 2026 - Filings
- 9 months ago - Scancell Holdings Slides: H1 2026 - Filings
- 9 months ago - Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma - GlobeNewsWire